Jaruskova, M., Curik, N., Hercog, R., Polivkova, V., Motlova, E., Benes, V., . . . Machova Polakova, K. (2017). Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment. J Exp Clin Cancer Res.
Chicago Style citaatJaruskova, Monika, et al. "Genotypes of SLC22A4 and SLC22A5 Regulatory Loci Are Predictive of the Response of Chronic Myeloid Leukemia Patients to Imatinib Treatment." J Exp Clin Cancer Res 2017.
MLA citatieJaruskova, Monika, et al. "Genotypes of SLC22A4 and SLC22A5 Regulatory Loci Are Predictive of the Response of Chronic Myeloid Leukemia Patients to Imatinib Treatment." J Exp Clin Cancer Res 2017.
Let op: Deze citaties zijn niet altijd 100% accuraat.